Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reductio ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

Fat tissue may commit weight to memory. For people living with obesity, losing weight can help reduce the risk of health problems such as type 2 diabetes or cardiovascular disease (SN: 2/29/24). But ...